Gondaliya P, Zinn DA, Sayyed AA, Driscoll J, Yan IK, Mensali N, Wälchli S, Patel T(2026) Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells Mol Pharm, 23(9), 4540-4552 DOI 10.1021/acs.molpharmaceut.6c00219, PubMed 42704135
Krawczyk M, Fidyt K, Fernandez-Fuentes N, Winiarski T, Pepek M, Bousquets-Muñoz P, Puente XS, Gutiérrez-Fernández A, Davis J, Owczarek D, Graczyk-Jarzynka A, Sanz-Galarreta P, Menendez P, Szumera-Ciećkiewicz A, Benard E, Wälchli S, Thomas-Tikhonenko A, Pérez-García VM, Galán-Gómez V, Escudero López A, Delgado EI, Minguillón J, Pérez-Martínez A, Winiarska M(2026) Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy Leukemia(in press) DOI 10.1038/s41375-026-03081-3, PubMed 42660975
Rovesti G, Woodbridge AF, Yao H, Pancaldi A, Chiavelli C, Gatto F, Sandvick U, Sällberg M, Fuxe J, Dominici M, Grönlund H, Nilsson OB, Nascimento Silva D, Pasetto A(2026) Immunogenomic profiling reveals targets for gene therapy in pediatric brain tumors Neurooncol Adv, 8(1), vdag193 DOI 10.1093/noajnl/vdag193, PubMed 42592420
